The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.
about
Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer modelThe Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem CellsCommon stemness regulators of embryonic and cancer stem cellsIdentifying and targeting tumor-initiating cells in the treatment of breast cancerObesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issueTargeting SH2 domains in breast cancerHwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenograftsPD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinationsMolecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerA novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLCBuoyancy-activated cell sorting using targeted biotinylated albumin microbubbles.STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious.Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies.Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferationSTAT3 and epithelial-mesenchymal transitions in carcinomasSalinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells.HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Top Notch cancer stem cells by paracrine NF-κB signaling in breast cancer.Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.Biomarkers to Target Heterogeneous Breast Cancer Stem CellsTranscription Factor STAT3 as a Novel Molecular Target for Cancer Prevention.Novel therapeutic strategies in the treatment of triple-negative breast cancer.Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survivalKinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancerXBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.A chemical biology approach to developing STAT inhibitors: molecular strategies for accelerating clinical translationBone marrow endothelium-targeted therapeutics for metastatic breast cancerTargeting autophagy in breast cancer.Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1.Bioinformatic analysis reveals a pattern of STAT3-associated gene expression specific to basal-like breast cancers in human tumorsClinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways.ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.TLR9 is critical for glioma stem cell maintenance and targeting.Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signalingTherapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.The transcriptional modulator BCL6 as a molecular target for breast cancer therapyDrug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer.Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells
P2860
Q21090788-811F7F19-7C5B-4014-A3E8-36574CC6375CQ26765892-CFEEB79A-C83B-41BD-B9AB-ACE080E64337Q26777882-C663F163-0878-499F-8500-318559285090Q26851827-6B22441A-D15B-4C60-A62C-C321B22AAC14Q26864117-41375280-B9AB-42C4-ACFF-F4D25578011CQ27014674-C426B2A2-8A44-46DB-A79D-A4080D90F1C0Q27334603-B72EC822-2998-423A-BEA8-8DECBACFA465Q28075712-DB8B6157-08B8-4C7A-94F4-4E8350E38EB1Q28076041-90D94944-E25C-4DAD-B819-3DD89C4C7340Q28387995-41A8999E-3488-4823-80CE-F4B4C661E1A2Q30410757-63554022-92FD-483F-9465-9383E3155666Q30577489-5E9A6760-3774-49C8-8E80-F3148C8845BFQ30843748-463CECDD-294B-4E9A-A557-EB707F6859A9Q33563809-431D9FFD-7C97-4F57-9C46-20CE9F73641EQ33591876-17A7919E-F3CA-412F-80C7-882263870F34Q33612070-EB50D2CF-88C1-4CE5-A234-056FEF155F87Q33623947-E2473B2B-354E-4374-A9C0-E8C42B495B14Q33658135-00DCBE11-8303-4373-8607-96EADEFD79D5Q33737278-BED766E7-F0D2-4410-89CF-F9BA82959F5EQ33745632-061DD144-58C1-4BD2-B6EF-094A781C1A97Q33769821-C674F908-7F13-4369-9706-FAB203723D9FQ33811149-FA7283C4-357B-4BF0-B926-76019CECDE7DQ33820278-3318135B-7A11-4EAE-90C9-6715DFEE5DF2Q33887682-D9F4E528-9760-454E-8AC4-DD2F9307CB9AQ33898664-A9EDDA84-663E-4D9D-ACAF-38785A25A1C4Q33917578-60460CE8-B067-43D7-9E46-039A68D32270Q33926690-123758CB-E282-4126-958F-512A0EB95A6AQ33934987-9428986F-6B1F-4AAF-A54E-5865565F88BFQ33943576-B66D49E2-A9D4-49D5-9A55-99D692F242F5Q34023616-49226418-1E39-4D4A-B0FC-ED6D849B348DQ34066920-3E2861EF-F8C1-4980-844A-8F3EAE47747EQ34144598-926BBC12-DCCE-4E1F-B2C8-AD7A26B36F8BQ34147910-EB8DD7DA-92D2-46D7-B94C-1B2794527097Q34148155-B3FB9EF4-6DDB-4000-9001-BCF42397437EQ34204722-3EA58A8C-156D-46A8-92B4-96DF538A7B43Q34227685-D504B3A8-41C9-49F3-909E-08B054A94B93Q34227776-5C2851C6-8FFA-4605-96B8-ABE7C8E55377Q34245186-96765061-85B7-4F19-82A9-23793F43E582Q34276296-DE7A850B-7E3A-4C60-B2AA-16349EB6E294Q34344849-035940B2-AD41-4FF9-8364-CE87C4D5DD58
P2860
The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The JAK2/STAT3 signaling pathw ...... cancer cells in human tumors.
@ast
The JAK2/STAT3 signaling pathw ...... cancer cells in human tumors.
@en
type
label
The JAK2/STAT3 signaling pathw ...... cancer cells in human tumors.
@ast
The JAK2/STAT3 signaling pathw ...... cancer cells in human tumors.
@en
prefLabel
The JAK2/STAT3 signaling pathw ...... cancer cells in human tumors.
@ast
The JAK2/STAT3 signaling pathw ...... cancer cells in human tumors.
@en
P2093
P2860
P356
P1476
The JAK2/STAT3 signaling pathw ...... cancer cells in human tumors.
@en
P2093
Andrea L Richardson
Andriy Marusyk
David A Frank
David E Root
Hee Eun Lee
Janina Schemme
Jessica J Kim
Karen S Anderson
Kornelia Polyak
Laura A Mulvey
P2860
P304
P356
10.1172/JCI44745
P407
P50
P577
2011-07-01T00:00:00Z